Molo, Jayden A.
HRN: 26-64-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/09/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
02/09/2025
02/15/2025
PO
3ml
Q8h
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes